Abstract: A method and system for image feature classification using a NN-based learning algorithms to make a decision about a feature in a medical image or image part. In particular, embodiments may make use of a phase of a multi-phasic image to improve classification accuracy. For instance, embodiments may combine different phases of multiphasic images as training data.

Abstract: Techniques for static script malware detection with semantic code representations are described. A request to perform a static malware detection analysis is received, the request identifying a script comprising code. A semantic representation of the script is generated, the semantic representation including context about statements in the code of the script. A feature space embedding is generated based at least in part on the semantic representation of the script. generating, based at least in part on the feature space embedding, A result indicating whether the script is malicious is generated based at least in part on the feature space embedding. An identification of the script and the result is stored in an entry in a log.

Abstract: Provided herein are inhibitors of AKT1, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the AKT1 inhibitory compounds for the treatment of disease.

Abstract: This disclosure provides an antenna, an antenna system, and a vehicle, and pertains to the field of wireless communication technologies. The antenna includes a main antenna, a parasitic antenna, and a mainboard, where the main antenna and the parasitic antenna are both located on a surface of the mainboard, and a plane on which the main antenna is located and a plane on which the parasitic antenna is located are parallel, and are opposite to each other. A feeding point of the main antenna is connected to a feeding transmission line of the mainboard, and the parasitic antenna is connected to a second ground end of the mainboard. A difference between a resonance frequency point of the main antenna and a resonance frequency point of the parasitic antenna is less than a target threshold.

Abstract: The present invention provides a dry mix composition of a low-viscosity cellulose ether (50 to 750 mPa·s at 1 wt. % solids, at 20 C, and a 514 s-1 shear rate, using a strain-controlled rotational rheometer (for example, ARES-G2™, TA Instruments), a graded aggregate, and a hydraulic cement, or a granular wet cement composition of the cement, graded aggregate and an admixture therefor including the cellulose ether. The wet granular hydraulic cement composition behaves like asphalt compositions and has zero or near zero slump, a high lubricity and from 5 wt. % to less than 13 wt. % of water, or, preferably from greater than 5 to 10.5 wt. %, based on the total weight of the granular wet cement composition. The low-viscosity cellulose ether enables lubricity without impairing compaction and without causing air entrainment.

Abstract: Provided herein are inhibitors of KRAS, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the KRAS inhibitory compounds for the treatment of diseases or disorders.

Abstract: The present application discloses a method for encryption of obfuscation code, an apparatus, a device and a readable medium. The method for encryption of obfuscation code includes: obtaining position information of all of function codes in a to-be-encrypted program; based on the position information, determining, one by one, whether a skipping instruction exists in the corresponding function code; when a skipping instruction exists in one of the function codes, saving the skipping instruction and corresponding address information into a decryption datum body, and replacing the skipping instruction with a breakpoint instruction; and in response to execution of the preceding one step being completed for all of the function codes, based on the decryption datum body and an encrypted program obtained by replacing the instructions, generating an encrypted file.

Abstract: Provided is a bispecific recombinant protein, comprising a high affinity tumor-targeting arm and a low affinity fusion protein blocking the interaction of CD47 with SIRP?. The antibody corresponding to the high affinity tumor-targeting arm does not bind to CD47, and its binding affinity to the target antigen on the tumor cell is at least 6 times as great as the binding affinity of monomer fusion protein homodimer, corresponding to the low affinity fusion protein blocking the interaction of CD47 with SIRP?, to a CD47 on the tumor cell, wherein the low affinity fusion protein blocking the interaction of CD47 with SIRP? comprises a SIRP? extracellular truncation. Also provided are nucleic acid molecules encoding recombinant proteins and the use of the recombinant proteins and nucleic acid molecules in the manufacture of a medicament for treating tumors.

Abstract: Provided herein are inhibitors of KRAS, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the KRAS inhibitory compounds for the treatment of diseases or disorders.

Abstract: Provided herein are inhibitors of KRAS, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the KRAS inhibitory compounds for the treatment of diseases or disorders.

Abstract: The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.

Abstract: A display panel includes a display area, a peripheral area and an opening area. The display panel includes: first data lines including first sub-data lines and second sub-data lines; data selectors including first data selectors and second data selectors, where the first data selectors are electrically connected with the first sub-data lines, and the second data selectors are electrically connected with the second sub-data lines; a plurality of data signal input terminals; a plurality of first data selection data lines including first sub-data selection data lines and second sub-data selection data lines, where the first sub-data selection data lines are electrically connected with the first data selectors, and the second sub-data selection data lines are electrically connected with the second data selectors and the data signal input terminal; and a plurality of first connection leads located outside the opening area and extending from the display area to the peripheral area.

Abstract: Provided herein are inhibitors of KRAS, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the KRAS inhibitory compounds for the treatment of diseases or disorders.

Abstract: The present application discloses a method for encryption of obfuscation code, an apparatus, a device and a readable medium. The method for encryption of obfuscation code includes: obtaining position information of all of function codes in a to-be-encrypted program; based on the position information, determining, one by one, whether a skipping instruction exists in the corresponding function code; when a skipping instruction exists in one of the function codes, saving the skipping instruction and corresponding address information into a decryption datum body, and replacing the skipping instruction with a breakpoint instruction; and in response to execution of the preceding one step being completed for all of the function codes, based on the decryption datum body and an encrypted program obtained by replacing the instructions, generating an encrypted file.

Abstract: A display panel includes a display area, a peripheral area and an opening area. The display panel includes: first data lines including first sub-data lines and second sub-data lines; data selectors including first data selectors and second data selectors, where the first data selectors are electrically connected with the first sub-data lines, and the second data selectors are electrically connected with the second sub-data lines; a plurality of data signal input terminals; a plurality of first data selection data lines including first sub-data selection data lines and second sub-data selection data lines, where the first sub-data selection data lines are electrically connected with the first data selectors, and the second sub-data selection data lines are electrically connected with the second data selectors and the data signal input terminal; and a plurality of first connection leads located outside the opening area and extending from the display area to the peripheral area.

Abstract: Embodiments of the present disclosure are directed towards coated fertilizer granule compositions that include two polyurethane layers and an optional wax layer.

Abstract: Provided herein are inhibitors of KRAS, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the KRAS inhibitory compounds for the treatment of diseases or disorders.

Abstract: The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.

Abstract: Disclosed are a bispecific recombinant protein and a use thereof. The bispecific recombinant protein comprises a first functional binding region, a second functional binding region and an Fc region; the first functional binding region comprises a first chain and a second chain, and a C-terminus of the first chain and a C-terminus of the second functional binding region are separately connected to an N-terminus of the Fc region directly or by means of a linker sequence; and a C-terminus of the second chain is connected to an N-terminus of the second functional binding region directly or by means of a linker sequence. Further disclosed is an application of the recombinant protein in terms of anti-tumor, anti-virus, liver disease treatment, and other applications. The recombinant protein may significantly improve the killing efficacy of target cells while significantly reducing toxic side effects caused by binding to non-target cells, and has good safety and good freeze-thaw stability.

Abstract: Layering of initially mixed granular dissimilar material components deposited by surface flow is realized by varying the relative angle of the flowing layer periodically with respect to the bulk of the pile formed. Layer thickness and extent can be controlled by varying the timing and extent of the surface variations. Variation in surface flow rates may be realized by varying the feed rate from an inlet to a collection base at a fixed feed location, varying the feed location relative to the collection base, tilting the collection base that is supporting the material, and reducing the pile repose angle using vibration or fluid flow through the base.